SCHEMBL25005925

SCHEMBL25005925

O=C(NCCN1CCOCC1)c1cccc(NC(=O)c2ccc([N+](=O)[O-])o2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 6/20 0.63
▸ RAB9A P51151 3/20 0.56
▸ NPC1 O15118 1/20 0.56
▸ KMT2A Q03164 6/20 0.55
▸ ALDH1A1 P00352 5/20 0.55
▸ MEN1 O00255 5/20 0.55
▸ MAPT P10636 3/20 0.55
▸ GAA P10253 2/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ JAK2 O60674 1/20 0.53
▸ DDIT3 P35638 1/20 0.52
▸ LMNA P02545 2/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ PAX8 Q06710 1/20 0.52
▸ MITF O75030 3/20 0.52
▸ POLB P06746 1/20 0.52
▸ HTT P42858 1/20 0.52
▸ CSF1R P07333 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24291375 0.95 EPHX2 (0.56) EPHX2RAB9ANPC1KMT2AALDH1A1
SCHEMBL25005417 0.80 JAK2 (0.67) RAB9ANPC1KMT2AALDH1A1MEN1
SCHEMBL25006066 0.80 JAK2 (0.61) RAB9ANPC1KMT2AALDH1A1MEN1
SCHEMBL24291456 0.79 LMNA (0.71) RAB9ANPC1KMT2AALDH1A1MEN1
SCHEMBL28024114 0.79 POLB (0.73) EPHX2KMT2AALDH1A1MEN1SMN1; SMN2
SCHEMBL6427938 0.78 RAB9A (0.78) RAB9ANPC1KMT2AALDH1A1MEN1
SCHEMBL25005574 0.77 JAK2 (0.64) RAB9ANPC1KMT2AALDH1A1MEN1
SCHEMBL22822784 0.77 JAK2 (0.58) RAB9ANPC1KMT2AALDH1A1MEN1
SCHEMBL22822605 0.77 JAK2 (0.72) RAB9ANPC1KMT2AALDH1A1MEN1
SCHEMBL12514132 0.77 EPHX2 (0.73) EPHX2ALDH1A1SMN1; SMN2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112107568-B Diaryl amide compound and application thereof 北京龙嘉博创医药科技有限公司 2022-03-25 — — CN claimed
CN-112107568-A Diaryl amide compound and application thereof 北京大学 2020-12-22 — — CN claimed
US-20230045031-A1 Diarylamide Compound and Application Thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2023-02-09 — — US disclosed
CN-112107568-B Diaryl amide compound and application thereof 北京龙嘉博创医药科技有限公司 2022-03-25 — — CN disclosed
CN-112107568-A Diaryl amide compound and application thereof 北京大学 2020-12-22 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230045031-A1 Diarylamide Compound and Application Thereof SLC14A1, SLC28A1, SLC28A2 EPHX2 3260/4885RAB9A 779/4885NPC1 177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback